» Articles » PMID: 18308838

Progestin Receptor Subtypes in the Brain: the Known and the Unknown

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2008 Mar 1
PMID 18308838
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Progesterone (P), the most biologically active progestin of ovarian origin, modulates numerous cellular functions in the central nervous system to coordinate physiology and reproduction. The neurobiological activity of P is mediated not by a single form of the progestin receptor (PR), but by two neural isoforms of PRs, PR-A and PR-B. Classical model of P action assumes that these neural effects are primarily mediated via their intracellular PRs, acting as transcriptional regulators, in steroid-sensitive neurons, modulating genes and genomic networks. Evidence has emerged, however, that activation of neural PRs is much more diverse; four distinct classes of molecules, neurotransmitters, peptide growth factors, cyclic nucleotides, and neurosteroids have been shown to activate the PRs via cross-talk and pathway convergence. In addition, rapid signaling events associated with membrane receptors and/or subpopulations of cytoplasmic PRs, via activation of protein kinase cascades, regulate PR gene expression in the cytoplasm independent of PR nuclear action. The increasing in vitro and in vivo evidence of differential transcriptional activities and coregulator interactions between PR-A and PR-B predict that these isoforms could have distinct roles in mediating additional and/or alternate signaling pathways within steroid-sensitive neurons. In this minireview, we evaluate the available data and discuss the possible roles of the isoforms in the regulation of neurobiological processes.

Citing Articles

Progesterone-mediated remodeling of the maternal-fetal interface by a PGRMC1-dependent mechanism.

Wang F, Ferreira L, Mazzanti A, Yu H, Gu B, Meissner T J Reprod Immunol. 2024; 163:104244.

PMID: 38555747 PMC: 11151737. DOI: 10.1016/j.jri.2024.104244.


CmPn/CmP Signaling Networks in the Maintenance of the Blood Vessel Barrier.

Gnanasekaran R, Aickareth J, Hawwar M, Sanchez N, Croft J, Zhang J J Pers Med. 2023; 13(5).

PMID: 37240921 PMC: 10222701. DOI: 10.3390/jpm13050751.


Progesterone: The Key Factor of the Beginning of Life.

Bulletti C, Bulletti F, Sciorio R, Guido M Int J Mol Sci. 2022; 23(22).

PMID: 36430614 PMC: 9692968. DOI: 10.3390/ijms232214138.


Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.

De Nicola A, Meyer M, Garay L, Kruse M, Schumacher M, Guennoun R Cell Mol Neurobiol. 2021; 42(1):23-40.

PMID: 34138412 PMC: 11441202. DOI: 10.1007/s10571-021-01118-y.


Sex Steroids as Regulators of Gestural Communication.

Tobiansky D, Fuxjager M Endocrinology. 2020; 161(7).

PMID: 32307535 PMC: 7316366. DOI: 10.1210/endocr/bqaa064.


References
1.
Guerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I . Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull. 2002; 59(2):105-9. DOI: 10.1016/s0361-9230(02)00845-6. View

2.
Kraus W, Montano M, Katzenellenbogen B . Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters. Mol Endocrinol. 1993; 7(12):1603-16. DOI: 10.1210/mend.7.12.8145766. View

3.
Schneider W, Ramachandran C, Satyaswaroop P, Shyamala G . Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form. J Steroid Biochem Mol Biol. 1991; 38(3):285-91. DOI: 10.1016/0960-0760(91)90099-q. View

4.
Mulac-Jericevic B, Lydon J, DeMayo F, Conneely O . Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci U S A. 2003; 100(17):9744-9. PMC: 187836. DOI: 10.1073/pnas.1732707100. View

5.
Tora L, Gronemeyer H, TURCOTTE B, Gaub M, Chambon P . The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature. 1988; 333(6169):185-8. DOI: 10.1038/333185a0. View